Sarath Kumar Pakalapati
About Sarath Kumar Pakalapati
Data last updated:
Sarath Kumar Pakalapati has 21 years in corporate governance. Holds Director role. Currently with 3 companies, including Mahi Drugs Private Limited and Haleos Labs Limited. Formerly with 4 companies, such as Sms Pharmaceuticals Limited and Neha International Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹386 Cr; the largest is Haleos Labs Limited at ₹350 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Haleos Labs Limited L74930TG2006PLC050223 | Director | 25 May 2017 | 2006 | ₹350 Cr (FY 2025) | Active |
 Mahi Drugs Private Limited U24233AP2012PTC084875 | Director | 09 Aug 2022 | 2012 | ₹35.66 Cr (FY 2023) | Active |
| Shreyas Management And Services Private Limited U74140TG1992PTC013819 | Director | 16 Dec 2011 | 1992 | ₹35.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sms Pharmaceuticals Limited L24239TG1987PLC008066 | Director | 12 Aug 2014 | 1987 | ₹789 Cr (FY 2025) | Active |
 Neha International Limited L01122TG1993PLC015987 | Director | 06 Jun 2005 | 1993 | ₹324 Cr (FY 2018) | Active |
| Vigilance India Consultants Private Limited U74999TG2007PTC056044 | Director | 23 Oct 2007 | 2007 | ₹8.56 Cr (FY 2025) | Active |
| Nischaya Insolvency Professionals Private Limited U74999TG2018PTC122118 | Director | 06 Feb 2018 | 2018 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarath Kumar Pakalapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarath Kumar Pakalapati
Sarath Kumar Pakalapati has 21 years in corporate governance. Holds Director role. Currently with 3 companies, including Mahi Drugs Private Limited and Haleos Labs Limited. Formerly with 4 companies, such as Sms Pharmaceuticals Limited and Neha International Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹386 Cr; the largest is Haleos Labs Limited at ₹350 Cr (FY 2025).
Sarath Kumar Pakalapati is associated with 3 companies as Director, including Haleos Labs Limited (₹350 Cr), Mahi Drugs Private Limited (₹35.66 Cr), Shreyas Management And Services Private Limited (₹35.1 Lakh).
Sarath Kumar Pakalapati has expertise in General Business.
Sarath Kumar Pakalapati has 21 years in corporate governance.
By reported revenue, the largest current company of Sarath Kumar Pakalapati is Haleos Labs Limited, with revenue of ₹350 Cr (FY 2025).
The 3 current companies of Sarath Kumar Pakalapati that report revenue have a combined latest revenue of ₹386 Cr.
Sarath Kumar Pakalapati currently holds positions at 3 companies: Haleos Labs Limited (₹350 Cr), Mahi Drugs Private Limited (₹35.66 Cr), Shreyas Management And Services Private Limited (₹35.1 Lakh).